Regenerative Medicine Institute of Nevada utilization adipose derived stem cells for deployment & clinical research. Early stem cell research has generally been connected with the controversial utilization of embryonic stem cells. The new focus is on non-embryonic adult mesenchymal stem cells which are discovered in an individual’s own blood, bone marrow, and fat. Most stem cell treatment centers in the world are presently utilizing stem cells derived from bone marrow.
A recent technological breakthrough enables us to now use fat derived stem cells. Autologous stem cells from an individual’s own fat are not difficult to gather securely under local anesthesia and are abundant in amounts up to 2500 times those seen in bone marrow.
Clinical success and favorable conclusions appear to be identified specifically to the amount of stem cells deployed. When these fat derived stem cells are administered back into the patient, they have the possibility to repair human tissue by forming new cells of mesenchymal origin, for example cartilage, bone, ligaments, tendons, nerve, fat, muscle, blood vessels, and certain internal organs. Stem cells’ capability to form cartilage and bone makes them conceivably highly viable in the treatment of degenerative orthopedic conditions. Their capability to structure new blood vessels and smooth muscle makes them conceivably extremely useful in the treatment of Peyronie’s disease and impotence. Stem cells are utilized widely within Europe and Asia to treat these conditions.
We have anecdotal and experimental evidence that stem cell therapy is needed in healing and regeneration. Stem cells search out damaged tissues to repair the body naturally. The medical journals and web is full of successful testimonials but we are still waiting for definitive studies exhibiting viability of stem cell therapy. Such information might take five or ten years to collect. In an effort to provide help for patients suffering from certain degenerative diseases that have been impervious to normal modalities of treatment, we are initiating pilot studies as trial tests of treatment effectiveness with exceptionally high amounts of adipose derived stem cells acquired from fat. Adipose is a plentiful and reliable source of stem cells.
Regenerative Medicine Institute of Nevada’s cell gathering and isolation strategies are based upon technology from Korea. This new technological leap forward permits patients to securely get their own autologous stem cells in extensive amounts. Our treatments and research are patient financed and we have tried fervently to make it affordable. All of our sterile procedures are non-invasive and done under local anesthesia. Patients who are searching for non-surgical options to their degenerative issues can participate in our trials by filling out our treatment application to verify if they are candidates. Regenerative Medicine Institute of Nevada is proud to be state of the art in the new field of Regenerative Medicine.